Strategy and core technologies for the secondary development of Chinese patent medicine.
- Author:
Bo-Li ZHAGN
1
;
Xiao-Hui FAN
2
;
Yang LIU
1
;
Hai-Bin QU
1
;
Jun-Hua ZHANG
1
;
Yi-Yu CHEGN
2
Author Information
1. Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China.
2. Department of Chinese Medicine Science and Engineering, Zhejiang University, Hangzhou 310058, China.
- Publication Type:Journal Article
- MeSH:
Drugs, Chinese Herbal;
chemistry;
economics;
Patents as Topic;
Technology, Pharmaceutical;
economics;
legislation & jurisprudence;
methods;
Translational Medical Research;
economics;
legislation & jurisprudence;
methods
- From:
China Journal of Chinese Materia Medica
2013;38(22):3797-3800
- CountryChina
- Language:Chinese
-
Abstract:
Secondary development of Chinese Patent Medicine (CPM) is an effective and innovation-driven way for the leaping development of Chinese medicine industry with less investment and faster return. Aim to improving the efficacy, safety and batch-to-batch consistency of CPMs, the theory and methodology for the secondary development of CPMs, mode for cultivating superior CPM, approaches to reforming the pharmaceutical technology and the corresponding core technologies were proposed in this paper, which is summarized as 'One objective, Three analyses, Five definitudes and Seven improvements'.
